Showing results (191-200 of 264) with videos related to
Sort By:
Pageof 27
Frontiers in Neurology|December 17, 2020
Neurological Complications and Noninvasive Multimodal Neuromonitoring in Critically Ill Mechanically Ventilated COVID-19 PatientsDenise Battaglini, Gregorio Santori, Karthikka Chandraptham, et al.Journal of Clinical Medicine|January 6, 2021
Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical ReviewChiara Robba, Denise Battaglini, Lorenzo Ball, et al.Clinical and Experimental Medicine|November 14, 2022
Intermediate monocytes expansion and homing markers expression in COVID-19 patients associate with kidney dysfunctionChiara Dentone, Daniela Fenoglio, Alessia Parodi, et al.Infectious Diseases and Therapy|April 11, 2022
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk FactorsFederica Briano, Laura Magnasco, Chiara Sepulcri, et al.Microorganisms|January 6, 2021
Spread of Carbapenem-Resistant Gram-Negatives and Candida auris during the COVID-19 Pandemic in Critically Ill Patients: One Step Back in Antimicrobial Stewardship?Laura Magnasco, Malgorzata Mikulska, Daniele Roberto Giacobbe, et al.The Journal of Antimicrobial Chemotherapy|March 15, 2025
Antipseudomonal cephalosporins versus piperacillin/tazobactam or carbapenems for the definitive antibiotic treatment of Pseudomonas aeruginosa bacteraemia: new kids on the ICU block?Davide Fiore Bavaro, Giuseppe Accurso, Silvia Corcione, et al.Critical Care (London, England)|February 25, 2021
Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumoniaLorenzo Ball, Chiara Robba, Lorenzo Maiello, et al.Journal of Fungi (Basel, Switzerland)|January 22, 2021
Utility of 1,3 β-d-Glucan Assay for Guidance in Antifungal Stewardship Programs for Oncologic Patients and Solid Organ Transplant RecipientsMarina Machado, Esther Chamorro de Vega, María Del Carmen Martínez-Jiménez, et al.Antibiotics (Basel, Switzerland)|February 14, 2020
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant EnterobacteralesAntonio Vena, Daniele Roberto Giacobbe, Nadia Castaldo, et al.Plos Pathogens|April 16, 2021
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severityFederica Bozzano, Chiara Dentone, Carola Perrone, et al.Pageof 27